The present invention relates to the use of an endogenous protein of immunitary origin, fractalkine, as a neuroprotective agent against glutamate toxicity in case of acute cerebral ischemia and spinal cord lesions. The agent is useful also in neurosurgery during operations on the brain as neuroprotective agent in case of blockage of blood circulation in the localized brain region subject to surgical intervention. Neuroprotection is exerted in the interval of a few hours after the ischemic insult and thus should be considered unique in the described pathophysiological applications.

Use of fractalkine for the production of a neuroprotector drug against cell death

FORNAI, FRANCESCO;
2007-01-01

Abstract

The present invention relates to the use of an endogenous protein of immunitary origin, fractalkine, as a neuroprotective agent against glutamate toxicity in case of acute cerebral ischemia and spinal cord lesions. The agent is useful also in neurosurgery during operations on the brain as neuroprotective agent in case of blockage of blood circulation in the localized brain region subject to surgical intervention. Neuroprotection is exerted in the interval of a few hours after the ischemic insult and thus should be considered unique in the described pathophysiological applications.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/117348
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact